Grace Therapeutics Statistics

Total Valuation

GRCE has a market cap or net worth of $30.87 million. The enterprise value is $20.77 million.

Market Cap	30.87M
Enterprise Value	20.77M

Important Dates

The next estimated earnings date is Thursday, May 15, 2025, before market open.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

GRCE has 13.72 million shares outstanding. The number of shares has increased by 34.86% in one year.

Current Share Class	13.72M
Shares Outstanding	13.72M
Shares Change (YoY)	+34.86%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	18.64%
Owned by Institutions (%)	9.63%
Float	9.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.45
P/TBV Ratio	11.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.06

Current Ratio	6.06
Quick Ratio	5.76
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -22.89% and return on invested capital (ROIC) is -17.83%.

Return on Equity (ROE)	-22.89%
Return on Assets (ROA)	-15.16%
Return on Invested Capital (ROIC)	-17.83%
Return on Capital Employed (ROCE)	-28.13%
Revenue Per Employee	n/a
Profits Per Employee	-$417,813
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-3.07M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.20
52-Week Price Change	n/a
50-Day Moving Average	3.03
200-Day Moving Average	n/a
Relative Strength Index (RSI)	36.84
Average Volume (20 Days)	32,847

Short Selling Information

The latest short interest is 38,342, so 0.28% of the outstanding shares have been sold short.

Short Interest	38,342
Short Previous Month	48,138
Short % of Shares Out	0.28%
Short % of Float	0.41%
Short Ratio (days to cover)	0.42

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.67M
Pretax Income	n/a
Net Income	-13.37M
EBITDA	-16.66M
EBIT	-16.67M
Earnings Per Share (EPS)	-$1.16

Full Income Statement

Balance Sheet

The company has $11.06 million in cash and n/a in debt, giving a net cash position of $11.06 million or $0.81 per share.

Cash & Cash Equivalents	11.06M
Total Debt	n/a
Net Cash	11.06M
Net Cash Per Share	$0.81
Equity (Book Value)	52.14M
Book Value Per Share	5.14
Working Capital	9.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.04 million and capital expenditures -$22,000, giving a free cash flow of -$14.06 million.

Operating Cash Flow	-14.04M
Capital Expenditures	-22,000
Free Cash Flow	-14.06M
FCF Per Share	-$1.02

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRCE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.86%
Shareholder Yield	n/a
Earnings Yield	-42.01%
FCF Yield	-44.18%

Analyst Forecast

The average price target for GRCE is $12.00, which is 433.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	433.33%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-11.98%

Stock Forecasts

Stock Splits

The last stock split was on July 10, 2023. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date	Jul 10, 2023
Split Type	Reverse
Split Ratio	0.1666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a